Latest News about APLS
Recent news which mentions APLS
From Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 17, 2023
From Benzinga
From Benzinga
From Benzinga
Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket
July 17, 2023
From Benzinga
From InvestorPlace
Apellis Pharma Flunks On Primary, Secondary Endpoints In Amyotrophic Lateral Sclerosis Study
May 25, 2023
From Benzinga
Why Shares of Annexon Are Plummeting Thursday
May 25, 2023
From Motley Fool
Why These 3 Nasdaq Stocks Buckled Today
May 16, 2023
From Motley Fool
From MarketWatch
Apellis Pharma's Newly Approved Drug Exceeds Sales Projections, Bullish Analyst Raises Expectations
May 05, 2023
Tickers
APLS
From Benzinga
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
May 01, 2023
From Motley Fool
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 26, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 19, 2023
From Benzinga
Wedbush Maintains Neutral Rating for Apellis Pharmaceuticals: Here's What You Need To Know
April 17, 2023
Tickers
APLS
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 12, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 03, 2023
From Benzinga
2 Best Growth Stocks to Buy in April
April 03, 2023
From Motley Fool
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 03, 2023
From Benzinga
Apellis Pharmaceuticals, VirTra And Other Big Stocks Moving Higher In Monday's Pre-Market Session
April 03, 2023
From Benzinga
Tickers
APLS
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.